You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : BANKING AND FINANCE
  3. INDUSTRY : FINANCIAL CONGLOMERATES
  4. CERO THERAPEUTICS HOLDINGS INC.

CERo Therapeutics Holdings Inc. XNAS: CERO

CERo Therapeutics Holdings Inc. Live Share Price Today, Share Analysis and Chart

Download real time

0.72 0.02 (2.86%)

New 52W Low in past week

2.0M XNAS Volume

High volume today

XNAS 04 Apr, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
0.0 / 100
Momentum Score
Technically Bearish
16.9 / 100
Analyst Price Target
No estimates available

6

S

10

W

4

O

0

T

SWOT Analysis

Check P/E Buy Sell Zone

Not enough data available


CERo Therapeutics Holdings... Live Price Chart

Switch to TradingView
Fetching data ...

CERo Therapeutics Holdings... Stock Analysis

CERo Therapeutics Holdings... stock analysis with key metrics, changes, and trends.

CERo Therapeutics Holdings... MetricVALUECHANGE %TRENDANALYSIS
Stock Price$0.72-99.63%negative

Stock Price fell 99.63% and underperformed its sector by 108.28% in the past year.

Quarterly Net profit$4.23 M213.33%negative

Quarterly Net profit fell 213.33% YoY to $4.23 M. Its sector's average net profit growth YoY for the quarter was 36.73%.

Mutual Fund Holding0.20 %0.02%positive

Mutual Fund Holding increased by 0.02% in the last quarter to 0.2.

Institutional Holding3.40 %0%neutral

Institutional Holding remained the same in the last quarter at 3.4%.



Loading data..

CERo Therapeutics Holdings Inc. - Company Profile

What does CERo Therapeutics Holdings Inc. do?

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

CERo Therapeutics Holdings Inc. Management structure

All Gross Remunerations are in USD
Mr. Brian G. Atwood
Chief Executive Officer and Chairman of the Board
-
2024
Gross Remuneration
Year
Mr. Chris Ehrlich
Interim Chairman of the Board and Chief Executive Officer
-
2024
Gross Remuneration
Year
Mr. Robert Steven Sikorski
Consultant
-
2024
Gross Remuneration
Year
Mr. Daniel Corey, M.D.
Chief Technical Officer and Director
-
2024
Gross Remuneration
Year
Mr. Charles Carter
Chief Financial Officer and Principal Accounting Officer
-
2024
Gross Remuneration
Year
Mr. Andrew Albert Kucharchuk
Chief Financial Officer
-
2024
Gross Remuneration
Year

CERo Therapeutics Holdings Inc. Board of directors

All Gross Remunerations are in USD
Mr. Brian G. Atwood
Director
-
2024
Gross Remuneration
Year
Ms. Kathleen D. Laporte
Director
-
2024
Gross Remuneration
Year
Mr. Chris Ehrlich
Interim Chairman of the Board and Chief Executive
-
2024
Gross Remuneration
Year
Mr. Michael Byrnes
Director
-
2024
Gross Remuneration
Year
Dr. Lindsey Rolfe, M.D.
Independent Director
-
2024
Gross Remuneration
Year
Mr. Daniel Corey, M.D.
Chief Technical Officer and Director
-
2024
Gross Remuneration
Year

CERo Therapeutics Holdings Inc. FAQ

How is CERo Therapeutics Holdings Inc. today?
CERo Therapeutics Holdings Inc. today is trading in the green, and is up by 2.86% at 0.72.
CERo Therapeutics Holdings Inc. is currently trading up 2.86% on an intraday basis. In the past week the stock fell -4.00%. stock has been down -87.63% in the past quarter and fell -99.63% in the past year. You can view this in the overview section.